Azurity announced today the successful completion of its acquisition of Covis. This strategic acquisition reinforces Azurity’s leadership in branded pharmaceuticals, harnessing the complementary strengths of both companies across multiple complex dosage forms and therapeutic areas. By combining expertise and resources, Azurity strengthens its ability to deliver medicines to overlooked patients on a global scale. #overlookedpatients #elevatingexcellence #covispharma #innovation #pharmaceuticals https://lnkd.in/eQvuteQJ
关于我们
Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of patients with underserved conditions. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span the cardiovascular, neurology, endocrinology, gastro-intestinal, institutional, and orphan markets, and have benefited millions of patients.
- 网站
-
https://www.azurity.com
Azurity Pharmaceuticals的外部链接
- 所属行业
- 制药业
- 规模
- 501-1,000 人
- 总部
- Woburn，Massachusetts
- 类型
- 私人持股
- 领域
- Specializes in providing safe, high-quality treatments for patients requiring customized formulations for their care.
地点
Azurity Pharmaceuticals员工
动态
-
Let's unite to raise awareness and support for those with rare diseases. #RareDiseaseDay
-
February is American Heart Month! Let's raise awareness about heart health and take steps towards a healthier lifestyle. #AmericanHeartMonth #HeartHealth
-
The World Drug Safety Congress Americas 2025 is excited to introduce?the latest industry experts who have joined our growing speaker lineup! ??? ? Dr. Philisha Mack,?Director of Drug Safety,?Azurity Pharmaceuticals ? Madhu S. Mondal PhD DABT,?Senior Director, Head of Toxicology,?Cerevel Therapeutics ? Mitra Tavakkoli MD, PharmD,?Vice President; Clinical Development,?4D Molecular Therapeutics This is your prime opportunity to hear from the brightest minds in the drug safety space?as they share groundbreaking insights on the latest advancements in?pharmacovigilance, signal detection, regulatory frameworks, patient safety, and beyond. ?????? ?? ???????????????? ?????? ?????????????? ???????? ?????????? ?????? ???????? ??????????: https://lnkd.in/gSanq3SV ??????????? ???????????? ?????? ???????????? & ?????????????? ???????????????????? ????????, ????????????????, & ???????????????? ?????????????????????????????? ?????????????????? ????????: https://lnkd.in/gcNNXRT3 Join #WorldDrugSafety's 2025?unparalleled speaker lineup and take the stage this fall ??? ?????????? ???? ?????????? ??????????:?https://lnkd.in/gsnPajnr Save the date: ??? November 4-6, 2025 ?? Boston Convention &?Exhibition Center
-
-
BREAKING: AZURITY PHARMACEUTICALS, INC. ANNOUNCES AVAILABILITY OF AZMIRO? (testosterone cypionate) injection for intramuscular use, CIII #overlookedpatients
-
We're heading to New Orleans, Louisiana for the ASHP Midyear Clinical Meeting & Exhibition December 8-12! Come visit us at booth 2133 to learn more about how Azurity is serving overlooked patients. #ASHP24 #overlookedpatients
-
-
We're heading to San Diego, California for the American Society of Hematology (ASH) Conference December 7-10! Come visit us at booth 2501 to learn more about how Azurity is serving overlooked patients. #ASH24 #overlookedpatients
-
-
We hope to see you at the American Epilepsy Society's (AES) Annual Meeting in Los Angeles, CA, December 6-10, 2024. Visit us at booth #2234 to learn more! #AES2024 #epilepsy #overlookedpatients
-
-
Join us in raising awareness of diabetes in our communities, supporting those affected, and reducing the risk during #NationalDiabetesAwarenessMonth this November. #diabetes #overlookedpatients
-
November is #NationalEpilepsyAwarenessMonth. Join us in recognizing both the advances in epilepsy care and the continued unmet needs of individuals and families living with this condition. #epilepsyawareness #overlookedpatients